Adenomatous polyposis coli (apc) gene mutation in a population of prostate cancer patients in osun state, nigeria
Authors:Olubunmi Ebenezer Esan, Yetunde Sophia Akinbo, Olalekan Adegoke Aremu , Abiola Adeyemi Adefidipe, Frederick Olusegun Akinbo
Int J Biol Med Res. 2024; 15(1): 7712-7717
Abstract:
It has been reported that the tumour suppressor gene germline adenomatous polyposis coli is mutated in many tumours particularly in prostate. This study was conducted to determine the APC gene mutations in prostate cancer patients in Osun State, Nigeria. Previously diagnosed paraffin wax tissue blocks with prostate cancer between 2014 and 2019 were selected for this study. Biodata information was obtained from the patient's request form and the laboratory surgical logbook. Sections were cut and stained for heamatoxylin and eosin staining technique to validate the diagnosis of prostate cancer previously reported. Sections for molecular analysis were dewaxed and macerated for DNA extraction. The APC-F “GGCAAGACCCAAACACATAATAG” and APC-R “GGAGATTTCGCTCCTGAAGAA” primers were used in the polymerase chain reaction and sequenced. The Big Dye terminator v3.1 cycle sequencing kit was used for sequencing the amplified fragments on an Applied Biosystems Genetic Analyzer 3130xl sequencer machine. This study observed mutations in the APC gene in some prostate cancer patients in Osun State, Nigeria. The mutations observed in this study involved the alanine nucleotides, glycine and an alanine-glycine nucleotide complex indicating the silent and missense mutations. In order to diagnose prostatic cancer early, manage and treat patients, routine genomic screening of males over 40 years is advocated.
https://www.biomedscidirect.com/archive/issue/76/articles
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...inventionjournals
An elevated level of cell-free DNA (cfDNA) in the blood circulation has detected in cancer patients in comparison with healthy controls. CfDNA circulation in plasma and serum extensively studied and the results are highly variable due to many factors influence the test results that was preanalytic factors as well as analytic factors. Objectives: Is there any difference in the concentration of serum DNA among patients with benign epithelial ovarian tumors and malignant epithelial ovarian tumors? What is the clinicopathological variable that influences the cfDNA circulation? Method: Venous blood drawn with plain vacutainer, centrifuged at 1,000 rpm for 30 minutes, serum kept in -800 C freezer. The cfDNA extracted used NaI method.Results: Collected 30 cases of the benign ovarian tumor and 54 cases of malignant ovarian tumors. The average level serum cfDNA of benign epithelial ovarian tumors and malignant epithelial ovarian tumors were 24.6 ng/mL and 22:29 ng/mL respectively and statistically was not significantly different (p = 0.64). In multivariable analysis with linear regression, there were no clinicopathological variables that statistically significant influence the cfDNA levels in patients with epithelial ovarian tumors where p > 0.05. Conclusion: Concentration of cfDNA circulation of benign epithelial ovarian tumors a little bit higher than malignant epithelial ovarian tumors, but statistically was not significantly different. There was no clinicopathological variable influence the concentration of cfDNA circulation of ovarian tumors.
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...inventionjournals
An elevated level of cell-free DNA (cfDNA) in the blood circulation has detected in cancer patients in comparison with healthy controls. CfDNA circulation in plasma and serum extensively studied and the results are highly variable due to many factors influence the test results that was preanalytic factors as well as analytic factors. Objectives: Is there any difference in the concentration of serum DNA among patients with benign epithelial ovarian tumors and malignant epithelial ovarian tumors? What is the clinicopathological variable that influences the cfDNA circulation? Method: Venous blood drawn with plain vacutainer, centrifuged at 1,000 rpm for 30 minutes, serum kept in -800 C freezer. The cfDNA extracted used NaI method.Results: Collected 30 cases of the benign ovarian tumor and 54 cases of malignant ovarian tumors. The average level serum cfDNA of benign epithelial ovarian tumors and malignant epithelial ovarian tumors were 24.6 ng/mL and 22:29 ng/mL respectively and statistically was not significantly different (p = 0.64). In multivariable analysis with linear regression, there were no clinicopathological variables that statistically significant influence the cfDNA levels in patients with epithelial ovarian tumors where p > 0.05. Conclusion: Concentration of cfDNA circulation of benign epithelial ovarian tumors a little bit higher than malignant epithelial ovarian tumors, but statistically was not significantly different. There was no clinicopathological variable influence the concentration of cfDNA circulation of ovarian tumors.
Analytical performance of a novel next generation sequencing assay for Myeloi...Thermo Fisher Scientific
To support clinical and translational research into precision oncology strategies for myeloid cancers, a next-generation sequencing (NGS) assay was developed to detect common and relevant somatic alterations. To define gene targets that were recurrently altered in myeloid cancers and relevant for clinical and translational research, an extensive survey of investigators at hematology oncology research labs was performed.
Development and Commercialisation of a Molecular Diagnostic CompanyMalavikaSankararaman
Development and commercialisation of a spin-out molecular diagnostics approach to detect different grades of Prostate Cancer using Fourier Transform Infrared Spectroscopy
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...inventionjournals
An elevated level of cell-free DNA (cfDNA) in the blood circulation has detected in cancer patients in comparison with healthy controls. CfDNA circulation in plasma and serum extensively studied and the results are highly variable due to many factors influence the test results that was preanalytic factors as well as analytic factors. Objectives: Is there any difference in the concentration of serum DNA among patients with benign epithelial ovarian tumors and malignant epithelial ovarian tumors? What is the clinicopathological variable that influences the cfDNA circulation? Method: Venous blood drawn with plain vacutainer, centrifuged at 1,000 rpm for 30 minutes, serum kept in -800 C freezer. The cfDNA extracted used NaI method.Results: Collected 30 cases of the benign ovarian tumor and 54 cases of malignant ovarian tumors. The average level serum cfDNA of benign epithelial ovarian tumors and malignant epithelial ovarian tumors were 24.6 ng/mL and 22:29 ng/mL respectively and statistically was not significantly different (p = 0.64). In multivariable analysis with linear regression, there were no clinicopathological variables that statistically significant influence the cfDNA levels in patients with epithelial ovarian tumors where p > 0.05. Conclusion: Concentration of cfDNA circulation of benign epithelial ovarian tumors a little bit higher than malignant epithelial ovarian tumors, but statistically was not significantly different. There was no clinicopathological variable influence the concentration of cfDNA circulation of ovarian tumors.
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...inventionjournals
An elevated level of cell-free DNA (cfDNA) in the blood circulation has detected in cancer patients in comparison with healthy controls. CfDNA circulation in plasma and serum extensively studied and the results are highly variable due to many factors influence the test results that was preanalytic factors as well as analytic factors. Objectives: Is there any difference in the concentration of serum DNA among patients with benign epithelial ovarian tumors and malignant epithelial ovarian tumors? What is the clinicopathological variable that influences the cfDNA circulation? Method: Venous blood drawn with plain vacutainer, centrifuged at 1,000 rpm for 30 minutes, serum kept in -800 C freezer. The cfDNA extracted used NaI method.Results: Collected 30 cases of the benign ovarian tumor and 54 cases of malignant ovarian tumors. The average level serum cfDNA of benign epithelial ovarian tumors and malignant epithelial ovarian tumors were 24.6 ng/mL and 22:29 ng/mL respectively and statistically was not significantly different (p = 0.64). In multivariable analysis with linear regression, there were no clinicopathological variables that statistically significant influence the cfDNA levels in patients with epithelial ovarian tumors where p > 0.05. Conclusion: Concentration of cfDNA circulation of benign epithelial ovarian tumors a little bit higher than malignant epithelial ovarian tumors, but statistically was not significantly different. There was no clinicopathological variable influence the concentration of cfDNA circulation of ovarian tumors.
Analytical performance of a novel next generation sequencing assay for Myeloi...Thermo Fisher Scientific
To support clinical and translational research into precision oncology strategies for myeloid cancers, a next-generation sequencing (NGS) assay was developed to detect common and relevant somatic alterations. To define gene targets that were recurrently altered in myeloid cancers and relevant for clinical and translational research, an extensive survey of investigators at hematology oncology research labs was performed.
Development and Commercialisation of a Molecular Diagnostic CompanyMalavikaSankararaman
Development and commercialisation of a spin-out molecular diagnostics approach to detect different grades of Prostate Cancer using Fourier Transform Infrared Spectroscopy
Clinical diagnosis of chronic myeloid leukemia by real time polymerase chain ...Teboho Mooko
Oncology study i did in my third year (2014). the study was basically about monitoring Chronic Myeloid leukemia (CML) using Real-Time PCR techniques to check how patients from Universitas Hospital responded to the treatment of Gleevec drug.
Comparing Mutation Detection Sensitivity from Matched FFPE Tissue and Liquid ...Thermo Fisher Scientific
Cancer researchers are avidly working to enable circulating cell free DNA (cfDNA) profiling as a new more sensitive tool to detect and screen for the presence of solid tumors before detection through clinical methods. Despite the high level of interest in cfDNA, researchers still have reservations until enough data has demonstrated complementarity between methodologies. In this study, we examined the data quality and concordance of mutations called for a small number of matched formalin fixed paraffin embedded (FFPE) tissue and plasma samples.
Association of common palb2 polymorphisms with ovarian cancer a case control ...IJARIIT
Background: The partner and localizer of breast cancer 2 (PALB2) has an essential role in BRCA2 mediated DNA
double-strand break repair by serving as a bridging molecule and acting as the physical and functional link between BRCA1&
2 proteins. Truncating mutations in the PALB2 gene are rare but are thought to be associated with increased risk of developing
breast and /or ovarian cancer in different populations. The present study was designed to investigate the variants of PALB2 and
their association with OC.
Material &Methods: A total of 150 histopathologically confirmed ovarian cancer patients and 250 healthy age matched controls
were collected. Three SNPs c.2794 G/A( rs45624036), c.1010 T/C(rs45494092), and c.1676A/G(rs152451) of PALB2 gene were
selected and genotyped by ARMS-PCR followed by agarose gel electrophoresis. Appropriate statistical tests were applied to test
for the significance of the results.
Results: A significant association of G/A (rs45624036) in inheritance models was observed & at the allelic level, the A allele
conferred four-fold increased risk compared to G allele. Regarding T/C (rs45494092) polymorphism all the models revealed an
association with OC and C allele showing eight-fold increased risk. With respect to A/G (rs152451) polymorphism, the protective
role was observed in tested inheritance models in OC patients.
The Haplo analysis for the combination of all the three variants revealed increased risk with A-T-A and G-C-G
haplotypes.(OR=4.50 ;95%CI 1.85-10.94;p=0.001,OR=26.36 ;95%CI 2.33 -297.91;p= 0.0085), whereas other haplotypes
conferred a protective role in OC.
Conclusions: The present study suggests an essential role of PALB2 in the etiology of ovarian cancer.
Millions of individuals worldwide are chronically exposed to arsenic through their drinking water. Our primary statistical analysis involved identifying differentially expressed genes between participants with and without arsenical skin lesions.In this study, genome-wide gene expression patterns was evaluated using RNA from peripheral blood lymphocytes of individuals. Our findings show that microarray-based gene expression analysis is a powerful method to characterize the molecular profile of arsenic exposure and arsenic-induced diseases.
Functional p53 is required for rapid restoration of daunorubicin-induced lesi...Enrique Moreno Gonzalez
The tumour suppressor and transcription factor p53 is a major determinant of the therapeutic response to anthracyclines. In healthy tissue, p53 is also considered pivotal for side effects of anthracycline treatment such as lesions in haematopoietic tissues like the spleen. We used a Trp53null mouse to explore the significance of p53 in anthracycline (daunorubicin) induced lesions in the spleen.
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Gul Muneer
We performed the first proteogenomic study on a prospectively collected colon cancer cohort. Comparative proteomic and phosphoproteomic analysis of paired tumor and normal adjacent tissues produced a catalog of colon cancer-associated proteins and phosphosites, including known and putative new biomarkers, drug targets, and cancer/testis antigens. Proteogenomic integration not only prioritized genomically inferred targets, such as copy-number drivers and mutation-derived neoantigens, but also yielded novel findings. Phosphoproteomics data associated Rb phosphorylation with increased proliferation and decreased apoptosis in colon cancer, which explains why this classical tumor suppressor is amplified in colon tumors and suggests a rationale for targeting Rb phosphorylation in colon cancer. Proteomics identified an association between decreased CD8 T cell infiltration and increased glycolysis in microsatellite instability-high (MSI-H) tumors, suggesting glycolysis as a potential target to overcome the resistance of MSI-H tumors to immune checkpoint blockade. Proteogenomics presents new avenues for biological discoveries and therapeutic development.
Porocarcinoma of the nose- reconstructed with seagull flap
Authors:Balasubramaniam, Ramanandham, Pradeep, Sivakumar, Kalpa Pandya
Int J Biol Med Res. 2024; 15(1): 7760-7763
https://www.biomedscidirect.com/2847/porocarcinoma-of-the-nose-reconstructed-with-seagull-flap
Surgical excision of infiltrative mammary lipoma in a twelve-year old local breed of bitch through modified radical mastectomy
Authors:Melkamu Birhanu Meharu & Jiregna Dugassa Kittesa
Int J Biol Med Res. 2024; 15(1): 7756-7759
https://www.biomedscidirect.com/2848/surgical-excision-of-infiltrative-mammary-lipoma-in-a-twelve-year-old-local-breed-of-bitch-through-modified-radical-mastectomy
More Related Content
Similar to Adenomatous polyposis coli (apc) gene mutation in a population of prostate cancer patients in osun state, nigeria.pdf
Clinical diagnosis of chronic myeloid leukemia by real time polymerase chain ...Teboho Mooko
Oncology study i did in my third year (2014). the study was basically about monitoring Chronic Myeloid leukemia (CML) using Real-Time PCR techniques to check how patients from Universitas Hospital responded to the treatment of Gleevec drug.
Comparing Mutation Detection Sensitivity from Matched FFPE Tissue and Liquid ...Thermo Fisher Scientific
Cancer researchers are avidly working to enable circulating cell free DNA (cfDNA) profiling as a new more sensitive tool to detect and screen for the presence of solid tumors before detection through clinical methods. Despite the high level of interest in cfDNA, researchers still have reservations until enough data has demonstrated complementarity between methodologies. In this study, we examined the data quality and concordance of mutations called for a small number of matched formalin fixed paraffin embedded (FFPE) tissue and plasma samples.
Association of common palb2 polymorphisms with ovarian cancer a case control ...IJARIIT
Background: The partner and localizer of breast cancer 2 (PALB2) has an essential role in BRCA2 mediated DNA
double-strand break repair by serving as a bridging molecule and acting as the physical and functional link between BRCA1&
2 proteins. Truncating mutations in the PALB2 gene are rare but are thought to be associated with increased risk of developing
breast and /or ovarian cancer in different populations. The present study was designed to investigate the variants of PALB2 and
their association with OC.
Material &Methods: A total of 150 histopathologically confirmed ovarian cancer patients and 250 healthy age matched controls
were collected. Three SNPs c.2794 G/A( rs45624036), c.1010 T/C(rs45494092), and c.1676A/G(rs152451) of PALB2 gene were
selected and genotyped by ARMS-PCR followed by agarose gel electrophoresis. Appropriate statistical tests were applied to test
for the significance of the results.
Results: A significant association of G/A (rs45624036) in inheritance models was observed & at the allelic level, the A allele
conferred four-fold increased risk compared to G allele. Regarding T/C (rs45494092) polymorphism all the models revealed an
association with OC and C allele showing eight-fold increased risk. With respect to A/G (rs152451) polymorphism, the protective
role was observed in tested inheritance models in OC patients.
The Haplo analysis for the combination of all the three variants revealed increased risk with A-T-A and G-C-G
haplotypes.(OR=4.50 ;95%CI 1.85-10.94;p=0.001,OR=26.36 ;95%CI 2.33 -297.91;p= 0.0085), whereas other haplotypes
conferred a protective role in OC.
Conclusions: The present study suggests an essential role of PALB2 in the etiology of ovarian cancer.
Millions of individuals worldwide are chronically exposed to arsenic through their drinking water. Our primary statistical analysis involved identifying differentially expressed genes between participants with and without arsenical skin lesions.In this study, genome-wide gene expression patterns was evaluated using RNA from peripheral blood lymphocytes of individuals. Our findings show that microarray-based gene expression analysis is a powerful method to characterize the molecular profile of arsenic exposure and arsenic-induced diseases.
Functional p53 is required for rapid restoration of daunorubicin-induced lesi...Enrique Moreno Gonzalez
The tumour suppressor and transcription factor p53 is a major determinant of the therapeutic response to anthracyclines. In healthy tissue, p53 is also considered pivotal for side effects of anthracycline treatment such as lesions in haematopoietic tissues like the spleen. We used a Trp53null mouse to explore the significance of p53 in anthracycline (daunorubicin) induced lesions in the spleen.
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Gul Muneer
We performed the first proteogenomic study on a prospectively collected colon cancer cohort. Comparative proteomic and phosphoproteomic analysis of paired tumor and normal adjacent tissues produced a catalog of colon cancer-associated proteins and phosphosites, including known and putative new biomarkers, drug targets, and cancer/testis antigens. Proteogenomic integration not only prioritized genomically inferred targets, such as copy-number drivers and mutation-derived neoantigens, but also yielded novel findings. Phosphoproteomics data associated Rb phosphorylation with increased proliferation and decreased apoptosis in colon cancer, which explains why this classical tumor suppressor is amplified in colon tumors and suggests a rationale for targeting Rb phosphorylation in colon cancer. Proteomics identified an association between decreased CD8 T cell infiltration and increased glycolysis in microsatellite instability-high (MSI-H) tumors, suggesting glycolysis as a potential target to overcome the resistance of MSI-H tumors to immune checkpoint blockade. Proteogenomics presents new avenues for biological discoveries and therapeutic development.
Porocarcinoma of the nose- reconstructed with seagull flap
Authors:Balasubramaniam, Ramanandham, Pradeep, Sivakumar, Kalpa Pandya
Int J Biol Med Res. 2024; 15(1): 7760-7763
https://www.biomedscidirect.com/2847/porocarcinoma-of-the-nose-reconstructed-with-seagull-flap
Surgical excision of infiltrative mammary lipoma in a twelve-year old local breed of bitch through modified radical mastectomy
Authors:Melkamu Birhanu Meharu & Jiregna Dugassa Kittesa
Int J Biol Med Res. 2024; 15(1): 7756-7759
https://www.biomedscidirect.com/2848/surgical-excision-of-infiltrative-mammary-lipoma-in-a-twelve-year-old-local-breed-of-bitch-through-modified-radical-mastectomy
Adapting to adversity: insights from a stand-alone human immunodeficiency virus testing centre in india during the covid-19 pandemic
Authors:Sumathi Muralidhar*, Abhishek Lachyan
Int J Biol Med Res. 2024; 15(1): 7750-7755
https://www.biomedscidirect.com/2857/adapting-to-adversity-insights-from-a-stand-alone-human-immunodeficiency-virus-testing-centre-in-india-during-the-covid-19-pandemic
Assessment of trend of mortality due to poisoning in the northern zone of india and comparison with other international & national researches
Authors:Naveen Sharma, Kunal Khanna, Kuldeep Kumar, Tarun Dagar, Sandeep Kumar Giri, Vijay Pal Khanagwal
Int J Biol Med Res. 2024; 15(1): 7741-7745
https://www.biomedscidirect.com/2824/assessment-of-trend-of-mortality-due-to-poisoning-in-the-northern-zone-of-india-and-comparison-with-other-international-national-researches
Pulmonary function and respiratory symptoms among petrol station workers in debre tabor town, northwest ethiopia, 2023
Authors:Deribew Abebaw Abuhay
Int J Biol Med Res. 2024; 15(1): 7724-7730
https://www.biomedscidirect.com/2853/pulmonary-function-and-respiratory-symptoms-among-petrol-station-workers-in-debre-tabor-town-northwest-ethiopia-2023
https://www.biomedscidirect.com/2835/bioremediation-and-information-technologies-for-sustainable-management?utm=articles
Bioremediation and information technologies for sustainable management
Authors:Jyoti Prakash, Aryan Shukla , Ruchi Yadav
Int J Biol Med Res. 2023; 14(4): 7702-7711 | Abstract | PDF File
Medical segregation cohort study of bio – medical waste management
Authors:Naval Kishor Lodha, Krishna Murari, Biramchand Mewara, Gopal Sharma, Mahendra varma
Int J Biol Med Res. 2023; 14(4): 7699-7701 | Abstract | PDF File
https://www.biomedscidirect.com/2829/an-overview-of-coronavirus-disease-covid-19?utm=articles
An overview of coronavirus disease (covid-19)
Authors:Emy Jancy Rani J.
Int J Biol Med Res. 2023; 14(4): 7687-7691 | Abstract | PDF File
Prevalence and associated risk factor of bovine calves coccidiosis in nekemt city, oromia, western ethiopia
Authors:Walkite Furgasa , Sosina Dawit , Shibiru Wako and Adisu Dube
Int J Biol Med Res. 2023; 14(4): 7660-7664 | Abstract | PDF File
Serum interleukin - 6 level among sudanese patients with chronic kidney disease
Authors:Safaa I.A Nasr , Rbab A.M Adam , Hala M.M Ibrahim , Afra S.A Abdelgadir , Ibrahim Alkider , Solomon M. Gamde , Simon P. Abriba
Int J Biol Med Res. 2023; 14(4): 7652-7654 | Abstract | PDF File
Assessment of cardiac histology and hematological parameters in adult male wistar rats exposed to exhaust emissions from gasoline generators
Authors:Akinpelu MORONKEJI, Frederick O AKINBO
Int J Biol Med Res. 2023; 14(4): 7638-7642 | Abstract | PDF File
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Adenomatous polyposis coli (apc) gene mutation in a population of prostate cancer patients in osun state, nigeria.pdf
1. Contents lists available at BioMedSciDirect Publications
Journal homepage: www.biomedscidirect.com
International Journal of Biological & Medical Research
Int J Biol Med Res. 2024; 15(1): 7712-7717
A R T I C L E I N F O A B S T R A C T
keywords
APC mutation
prostate cancer patients
Osun State.
It has been reported that the tumour suppressor gene germline adenomatous polyposis coli is
mutated in many tumours particularly in prostate. This study was conducted to determine the APC
genemutationsinprostatecancerpatientsinOsunState,Nigeria.Previouslydiagnosedparaffinwax
tissue blocks with prostate cancer between 2014 and 2019 were selected for this study. Biodata
information was obtained from the patient's request form and the laboratory surgical logbook.
Sections were cut and stained for heamatoxylin and eosin staining technique to validate the
diagnosis of prostate cancer previously reported. Sections for molecular analysis were dewaxed and
macerated for DNA extraction. The APC-F “GGCAAGACCCAAACACATAATAG” and APC-R
“GGAGATTTCGCTCCTGAAGAA” primers were used in the polymerase chain reaction and sequenced.
The Big Dye terminator v3.1 cycle sequencing kit was used for sequencing the amplified fragments
on an Applied Biosystems Genetic Analyzer 3130xl sequencer machine. This study observed
mutations in the APC gene in some prostate cancer patients in Osun State, Nigeria. The mutations
observed in this study involved the alanine nucleotides, glycine and an alanine-glycine nucleotide
complex indicating the silent and missense mutations. In order to diagnose prostatic cancer early,
manageandtreatpatients,routinegenomicscreeningofmalesover40yearsisadvocated.
BioMedSciDirect
Publications
International Journal of
BIOLOGICAL AND MEDICAL RESEARCH
www.biomedscidirect.com
Int J Biol Med Res
ADENOMATOUS POLYPOSIS COLI (APC) GENE MUTATION IN A POPULATION OF
PROSTATE CANCER PATIENTS IN OSUN STATE, NIGERIA
a b c d
Olubunmi Ebenezer Esan, Yetunde Sophia Akinbo, Olalekan Adegoke Aremu , Abiola Adeyemi Adefidipe,
e
Frederick Olusegun Akinbo
Department of Medical Laboratory Science, University of Benin, Benin City, Nigeria
Department of Medicine, University of Utah, Salt Lake City, USA
Department of Morbid Anatomy and Forensic Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria”
Original article
Introduction
Copyright 2023 BioMedSciDirect Publications IJBMR - All rights reserved.
ISSN: 0976:6685.
c
Globally, prostate cancer is the second-most common cancer. It is
the fifth-leading cause of cancer-related death in men. Prostate
cancer (PCa) is the most common cause of cancer death among
African men (1). PCa is the most common cancer among males,
resulting in over 1,193,715 new cases and 375,000 fatalities each
year(2).It isthemostcommoncancerdiseaseinmenin84countries,
occurring more commonly in developed countries (3). This disease
presents more aggressively among African men and it is uncertain
whether the increased aggression is an inherent biological
characteristic found in African patients or is a result of late-stage
diagnosis, which could affect disease treatment (4). The
epidemiology of prostate cancer provides some evidence that its
genesis is probably a combination of hereditary and environmental
factors(5).Specifically,epidemiologicalstudieshaveestablishedthat
afamilyhistoryofprostatecancersignificantlyincreasesrisk(6).
It has been reported that the tumour suppressor gene germline
adenomatous polyposis coli is mutated in many tumours (7). APC
protein promotes β-catenin degradation by binding to axin and
directlybindingtoβ-catenin.MutantAPCbindstoβ-cateninbutnot
to axin which causes inefficient phosphorylation, incomplete
degradation, and accumulation of β-catenin (8). APC gene
mutations were initially reported in familial adenomatous
polyposis in 1991. The progression from adenoma to cancer is
believed to involve multistage carcinogenesis with the
accumulation of APC, KRAS, and TP53 gene mutations (9). In the
presence of WNT ligands, or a mutation in the APC gene, β-catenin
is no longer degraded and can accumulate in both the cytosol and
thenucleus,whereitactivatestargetgeneexpressionprimarilyvia
interaction with the TCF/LEF DNA binding transcription factors
(10). The loss of APC function is thought to activate downstream
components of the canonical WNT signaling pathway (11, 12).
Numerous genetic mutations, together with epigenetic and gene
expression adjustments or alterations, have been shown to raise
the chance of developing prostate cancer (13, 14, 15). There are
several genes that, when mutated, increase the likelihood of
developing prostate cancer, among which is the APC gene (16).
Modernresearchhascenteredonfiguringoutthegeneticcausesof
prostate cancer. Information is lacking on APC gene mutation
among prostate cancer patients in Osun State. Against this
background, this study was conducted to determine the APC gene
mutationsinprostatecancerpatientsinOsunState,Nigeria.
* Corresponding Author : Dr.Frederick Olusegun Akinbo
Department of Medical Laboratory Science
School of Basic Medical Sciences University of Benin Benin City, Nigeria.
E-mail: fredrick.akinbo@uniben.edu
Copyright 2023 BioMedSciDirect Publications. All rights reserved.
c
2. Olubunmi Ebenezer Esan et al. Int J Biol Med Res. 2024; 15(1): 7712-7717
7713
MATERIALS AND METHODS
Studydesign
The specimens used in this study were obtained from the
Histopathology Laboratory's archives at the Obafemi Awolowo
University Teaching Hospital (OAUTH), Ile-Ife, Osun State.
Previously diagnosed paraffin wax tissue blocks with prostate
cancerbetween2014and2019wereselectedforthisstudy.Biodata
information was obtained from the patient's request form and the
laboratorysurgicallogbook.
Samplesizeofthisresearchwasdeterminedusingtheformula:
N=Z2P(1-P)/d2,(17)
WhenN=Samplesize
Z=Statistic for the level of confidence 95% which is
conventionally1.96
P=Estimatedprevalence(0.1875)
N=Requiredsample
D=AcceptedError(0.05)
N=1.9(2)X0.1875(1-0.1875)/0.05(2)
N=234Samples
A total of 234 paraffin wax tissue blocks diagnosed with
prostatecancerwereretrievedfromtheHistopathologyLaboratory
ofthehospitalandusedinthisstudy.
EthicalClearance
The protocol for this study was approved by the Ethics and
Research Committee of the Osun State Ministry of Health, Osogbo,
OsunState,Nigeria.
Specimencollectionandprocessing
Sections were cut at 3µ on a rotary microtome to validate the
diagnosis of prostate cancer on the selected paraffin wax blocks
from the Histopathology Laboratory archives of the OAUTH. The
sections were stained using the previously described method by
Avwioro (18). Briefly, the sections were dewaxed in 2 changes of
xylene, hydrated in descending grades of alcohol, and taken to
water.HydratedsectionswerestainedinCole'shaematoxylinfor10
min, rinsed in water and differentiated in 1% acid alcohol briefly.
Stained sections were rinsed in water, blued in running tap water
for 10 min and counterstained in 1% aqueous eosin for 3 min.
Stained sections were rinsed in water, dehydrated in ascending
grades of alcohol, cleared in 2 changes of xylene and mounted in
DPX. Sections were examined microscopically, and the previous
diagnosisofprostatecancerwasvalidated.
DNAextraction
Multiple serial sections were cut from the paraffin wax tissue
blocks, dewaxed in xylene, hydrated and ground in sterile mortar
and pestle for DNA extraction, 500 µl of extraction buffer was added
in an Eppendorf tube. Thirty-three microliter of 20% Sodium
Dodecyl Sulphate (SDS) was added, vortexed for a short time, and
incubated in a water bath at 65°C for 10 min and 10 µl of 5 M
potassium acetate was added, vortexed, and centrifuged at 10,000g
for10minat roomtemperature.AsecondEppendorftube wasused
to collect the supernatant, 300µl of cold isopropanol was added,
gently mixed, and then the tube was maintained at -20°C for 60 min.
The mixture was centrifuged at 13,000g for 10 min, and the
supernatant was carefully decanted. The DNA pellet was then
centrifuged at 10,000 g for 10min and rinsed in 500 µl of 70%
ethanol. The DNA pellet was air-dried at room temperature
following ethanol decantation. The pellet was then re-suspended in
50µlofTrisEDTAbuffer(19).
PolymeraseChainReaction
PCR sequencing preparation cocktail for all PCR consisted of 10
µl of 5x GoTaq colourless reaction, 3 µl of 25mM MgCl2, 1 µl of 10
mM of dNTPs mixed, 1 µl of 10 pmol each primers (Table1) and 0.3
units of Taq DNA polymerase (Promega, USA) made up to 35 µl with
sterile distilled water 15μl DNA template. PCR was carried out in a
GeneAmp 9700 PCR System Thermalcycler (Applied Biosystem Inc.
USA)withaPCRprofileforeachprimer.
The PCR sequencing preparation cocktail for all PCRs contained
10nl of a 5x GoTaq colorless reaction, 3 µl of 25 mM MgCl2, 1µl of a
10 mM dNTPs mix, 1µl of each 10 pmol primer, and 0.3 units of Taq
DNA polymerase (Promega, USA) made up to 35µl with sterile
distilled water and 15 µl DNA template. A PCR profile for each
primer was used during the PCR process in an Applied Biosystems
Gene Amp 9700 PCR System Thermal cycler (USA). The gel was
electrophoresedat120Vfor45minbeforebeingphotographedand
viewed under ultraviolet trans-illumination. By comparing the
mobility of a 100 bp molecular weight ladder with experimental
samples run alongside it in the gel, the sizes of the PCR products
werecalculated.
Table 1: Forward and Reverse Primers
Primer Primer sequence PCR Profile
APC-F GGCAAGACCCAAACACATAATAG Denaturation at 94°C
for 5 min; followed by
a 30 cycle consisting
of 94°C for 30 s, 48°C
for 30s and 72°C for
1 min; and final
termination at 72°C
for 10 min.
APC-R GGAGATTTCGCTCCTGAAGAA
3. 7714
All samples from group 1 and samples 3, 4 and 5 from group 3
had the A (Alanine) nucleotide while all samples from group 2 and
samples 7, 8 ,12 and 19 from group 3 had the G (Glycine) nucleotide.
This A-G (Alanine-Glycine) mutation, however, is a silent mutation
as both the A and G both coded for the same amino acid glutamine.
Another mutation along the partial sequenced APC gene was a T-C
(Threonine-Cysteine) mutation recorded at position 430. This T-C
(Threonine-Cysteine) mutation with 20 individuals having the T
nucleotideandonlysample43havingtheCnucleotideisamissense
mutation. Individuals with the T nucleotide translated to amino
acid serine while those with the C nucleotides translated to proline
(Figure1b).
The APC partial gene sequence was recorded at position 579.
This G-A (Glycine-Alanine) mutation occurred with a frequency of
11individualshavingtheGnucleotidewhile10individualshavethe
A nucleotide. All samples from group 1 and samples 3, 4, 5 from
group 3 including sample 22 from group 2 had the G (Glycine)
nucleotide while all samples from group 2 (sample 22) and samples
7, 8, 12 and 19 from group 3 had the G (Glycine) nucleotide. Also,
this A-G (Alanine-Glycine) mutation is a silent mutation as both the
A and G both coded for the same amino acid Leucine. Similar
mutation along the partial sequenced APC gene was noticed in the
T-C (Threonine-Cysteine) mutation recorded at position 626. This
T-Cmutationwith18individualshavingtheTnucleotideandonly3
individuals from group 1 (samples 1, 23 and 31) with the C
nucleotide is a missense mutation. Individuals with the T
nucleotide translated to amino acid Isoleucine while those with the
Cnucleotidestranslatedtothreonine(Figure1c).
At position 766, A-G (Alanine-Glycine) mutation was recorded
with 20 individuals having the nucleotide A and only sample 2 from
group 1 had the nucleotides G. This A-G (Alanine-Glycine) mutation
is a missense mutation as individuals with the A nucleotide
translated to amino acid Lysine while that with the G nucleotide
translatedtoaminoacidglutamicacid(Figure1d).
The final mutation identified along the partial sequenced APC
genewaslocatedatposition903.ThismutationisaT-C(Threonine-
Cysteine) mutation having a frequency of 19 individuals having the
G nucleotide and 2 individuals have the C nucleotide. This T-
C(Threonine-Cysteine) mutation is also a silent mutation as both
the T and C both coded for the same amino acid Phenylalanine
(Figure1e).
The phylogenetic tree has two major clusters from sample 27 to
sample 22 is a major cluster and from sample 4 to sample 1 is
anothermajorcluster.Firstclustercontainedmainlygroups3and2
whilesecondclustercontainedmainlygroups1and3(Figure2).
Plate 1: Gel electrophoresis for APC genes region of prostate
cancer tissue
Table 2: Gene alterations observed in prostate cancer tissue
blocks.
RESULTS
The amplified fragments were ethanol filtered to eliminate the
PCR reagents after gel integrity. In a new, sterile 1.5-l Eppendorf
tube, each 40-l PCR amplified product received 7.6 µl of Na acetate
3M and 240 µl of 95% ethanol. The mixtures were properly mixed
byvortexing,andthetubeswerethenkeptat-20°Cfor30min.After
centrifuging for 10 min at 13,000 g and 4°C, the supernatant was
decanted and the pellet cleansed by adding 150 µl of a 70% ethanol
mixture,at 7,500gcentrifugedat 4°Cfor15min.Beforesequencing,
supernatant was aspirated and dried in the fume hood at ambient
temperaturefor15min.TheDNApelletwasresuspendedin20µlof
sterile distilled water and stored at -20°C. The purified fragment
was quantified using a nanodrop of model 2000 from Thermo
Scientific and tested on a 1.5% Agarose gel run at 110V for 1hr to
confirmthepresenceofthepurifiedproduct.
Sequencing
The Big Dye Terminator v 3.1 cycle sequencing kit was used for
sequencing the amplified fragments on an Applied Biosystems
Genetic Analyzer 3130xl sequencer per the manufacturer's
instructions.Forallgeneticstudies,MEGA6andBio-Edittoolswere
utilized. A run blast analysis using the NCBI data website indicated
that all APC partial sequences were between 99-100% identical to
Homo sapiens APC regulator of WNT signaling pathway (APC),
transcript variant 1, mRNA. The sequences obtained for APC gene
were submitted to the NCBI gene bank and accession numbers
allotted were: (G1) OK357100-(G1) OK357106); (G2) OK357107-
(G2) OK357112; (G) OK 357113 and (G3) OK357114-(G3)
OK357120.
The aligned edited APC partial gene sequences generated from
the selected tissue blocks revealed the presence of potential SNPs
(singleNucleotidePolymorphism)alongthesequencedfragment.A
total of six potential mutations were recorded along the sequenced
fragments and these mutations varied in functions ranging from
silent mutation to missense mutation. Although all mutations were
point (Transition) mutations, three of these mutations were silent
mutations, as the effect of a nucleotide change didn't cause a change
in the amino acid sequence and were recorded at positions (on the
aligned sequence) 163, 579, and 903. The other three were
missensemutationsasthenucleotidechangeresultedinachangein
amino acid and was recorded at positions 430, 626, and 766 (Table
2). The presence of an A-G (Alanine-Glycine) mutation was
identified in position 163 with 10 individuals having the nucleotide
Aand11individualshavingthenucleotidesG(Figure1a).
Olubunmi Ebenezer Esan et al. Int J Biol Med Res. 2024; 15(1): 7712-7717
4. 7715
Figure 1a: Nucleotide alignment that showed the region of SNP
mutations along the APC gene in tissue of prostate cancer
patients.
Figure 1b: Nucleotide alignment that showed the region of SNP
mutations along the APC gene in tissue of prostate cancer
patients.
Figure 1c: Nucleotide alignment that showed the region of SNP
mutations along the APC gene in tissue of prostate cancer
patient
Figure 1d: Nucleotide alignment that showed the region of SNP
mutations along the APC gene in tissue of prostate cancer
patients.
The phylogenetic tree has two major clusters from sample 27 to
sample 22 and from sample 4 to sample 1. First cluster contained
mainly groups 3 and 2 while the second cluster consisted mainly of
groups1and3.
Figure2:Phylogeneticstudiesshowingtherelationshipamong
samplesalongtheAPCgene.
Olubunmi Ebenezer Esan et al. Int J Biol Med Res. 2024; 15(1): 7712-7717
Figure 1e: Nucleotide alignment that showed the region of SNP
mutations along the APC gene in tissue of prostate cancer
patients.
5. 7716
DISCUSSION
The understanding of the genetic events involved in the initial
onset and progression of prostate cancer has reportedly advanced
quite quickly due to advances in molecular technologies (20). The
development of our knowledge of the genetic, biochemical, and
metabolic anomalies of prostate cancer at various phases of the
disease's progression has made it easier to identify new potential
therapy targets (21). To our knowledge, this study is the first study
to determine the APC gene mutation in prostate cancer patients in
OsunState,Nigeria.
It has been reported that men with APC gene mutation are at
higher risk of developing prostate cancer (22). Apart from the
molecular changes observed at the somatic level in prostate tumor
cells, there are also variants at the germ line level, which means that
they exist in every cell in a man's body from the time of conception
and increase the likelihood of prostate cancer developing early in
life. Men who have a family history of prostate cancer, particularly
first-degree cases, are at a higher risk of developing the illness since
it may be a genetic condition (23). In this study, APC gene mutations
were observed at amino acid positions 163, 430, 579, 621, 766, and
903. In addition, a T-C(Threonine-Cysteine) mutation was found at
position430,anA-G(Alanine-Glycine)mutationatlocation163,aG-
A(Glycine-Alanine)mutationatposition579,andaT-C(Threonine-
Cysteine) mutation at position 621. A-G(Alanine-Cysteine) and T-
C(Threonine-Cysteine) mutations are found at positions 766 and
903, respectively. This observation is at variance with the report of
Umeda et al. (8), which observed mutations with heterozygosity
and focal nuclear translocation of β-catenin in prostate cancer
patients in Japan. The reasons for the difference in this study and
that of other authors may be attributed to aging and dietary habits
aswellasgeographicallocations.
The phylogenetic tree computed with edited sequences
amplified with APC specific primers clustered having two major
branches. This phylogenetic tree indicated high level of group
variation with group1 entirely in one branch whereas group 2 is in
another branch however, group 3 cuts across both branches. The
first branch consisted of a close relationship between samples 27,
12, 13, 15, 17, 18 and 11 (all in group 2) and this subbranch were
closely related to reference sequence LT855219, LT855215,
LT855223andLT855224.Withinthisbranchisanothersub-branch
consisting of group 3 samples 8, 7 and 19 with sample 22 (group 2)
out grouping itself from the clusters. Sample 22 differs from other
members of this group with a G-A mutation at position 579. The
second major branch in the tree is made up of a cluster sample 4, 3
and 5 of group 3 which is closely related to sample 42 of group 1 and
a second subbranch consisting of a cluster between sample 36 and
sample 2, sample 23 and sample 31 and is closely related to sample
1(allingroup1).Sample1,31and23differsfromtherestmembers
of this branch with a C:T mutation in position 626. Groups 2 and 3
were closely related compared to group 1 recording a genetic
differenceof0.000970.however,group2differsfromgroup1witha
genetic difference of 0.002758 while group 3 differs from group 1
with a genetic difference of 0.002186. This finding is consistent
with the report of Breyer et al. (24) that observed familial mutation
ontheAPCgenesofprostatecancer.
Conclusion
This study observed APC gene mutation in some prostate
cancer patients in Osun State, Nigeria. The mutations observed in
this study involved the alanine nucleotides, glycine, and an alanine-
glycine nucleotide complex indicating the silent and missense
mutations.
Acknowledgments
We sincerely appreciate the Management of the Obafemi
Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria
for allowing us to use their archival tissue blocks from the
Histopathology Laboratory for this study. Our profound gratitude
goes to the Head of the Department, Consultant Pathologists,
Deputy Director (MLS), and members of staff of the Department of
Histopathology, Obafemi Awolowo University Teaching Hospital,
Ile-Ife, Osun State for their cooperation and assistance in using
facilities.
References
[1] Temilola DO, Wium M, Paccez J, Salukazana AS, Rotimi SO, Otu HH, Carbone
GM, Kaestner L, Cacciatore S, Zerbini LF. Detection of Cancer-Associated Gene
Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South
Africa.Genes.2023;14:1884.doi.org/10.3390/genes14101884.
[2] International Agency for Research on Cancer, World Cancer Report 2014,
ed.Stewart BW and Wild CP: International Agency for Research on Cancer.
2014.
[3] Sung H, Ferlay J, Siegel RL. Laversanne M. Soerjomataram I, Jemal A, Bray F.
(2021).GlobalCancerStatistics 2020:GLOBOCAN Estimatesof Incidence and
Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin.
2021:71:209–249.
[4] Powell IJ. Epidemiology and Pathophysiology of Prostate Cancer in African-
AmericanMen.J.Urol.2007;177:444–449.
[5] Schulman CC, Zlotta AR, (2003). Prevention of Prostate Cancer: The Role of
Diet:ProstateCancer.Doi.org/10.1016/B978-012286981-5/50022-7
[6] Lange EM. 2010. Identification of genetic risk factors for prostate cancer:
analytic approaches using hereditary prostate cancer families. In Male
reproductive cancers: epidemiology, pathology and genetics (ed. Foulkes WD,
CooneyKA),Springer,NewYork.2010;203-228.
[7] Wachsmannova L, Mego M, Stevurkova V, Zajac V, Ciemikova S. Novel
strategies for comprehensive mutation screening of the APC gene.
Neoplasma.2017;64:338-343.
[8] Umeda K, Kosaka T, Nakamura K, Takeda T, Mikami S, Nishihara H, Oya M.
(2020). A Japanese patient with ductal carcinoma of the prostate carrying an
adenomatosis polyposis coli mutation: a case report. Diagnostic Pathol. 15:
102-105.
[9] Zhang L, Shay JW. (2017). Multiple roles of APC and its therapeutic
implicationsincolorectalcancer.JNationalCancerInst.109(8):djw332.
[10] Eastman Q, Grosschedl R (1999) Regulation of LEF-1/TCF transcription
factorsbyWntandothersignals.CurrOpinCellBiol11:233–240.
[11] Clevers H (2006) Wnt/beta-catenin signaling in development and disease.
Cell.127:469–480.
Olubunmi Ebenezer Esan et al. Int J Biol Med Res. 2024; 15(1): 7712-7717
6. 7717
[12] MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling:
components,mechanisms,anddiseases.DevCell.17:9–26.
[13] Adeola HA Soares, N.C.; Paccez, J.D.; Kaestner, L.; Blackburn, J.M.; Zerbini, L.F.;
Luiz,F.;Zerbini,L.F.DiscoveryofNovelCandidateUrinaryProteinBiomarkers
for Prostate Cancer in a Multiethnic Cohort of South African Patients via
Label-FreeMassSpectrometry.Proteom.-Clin.Appl.2015;9:597–609.
[14] Adeola, H.A.; Smith, M.; Kaestner, L.; Blackburn, J.M.; Zerbini, L.F. Novel
Potential Serological Prostate Cancer Biomarkers Using CT100+ Cancer
Antigen Microarray Platform in a Multi-Cultural South African Cohort.
Oncotarget.2016;7:13945–13964.
[15] Jaratlerdsiri, W.; Jiang, J.; Gong, T.; Patrick, S.M.; Willet, C.; Chew, T.; Lyons, R.J.;
Haynes, A.-M.; Pasqualim, G.; Louw, M.; et al. African-Specific Molecular
TaxonomyofProstateCancer.Nature.2022;609:552–559.
[16] Cooney KA. (2017). Inherited predisposition to prostate cancer: fromgene
discoverytoclinicalimpact.TransAmericanClinClimatolAssoc.128:14-23.
[17] Naing L, Winn T, Rusli BN. Practical Issues in Calculating the Sample Size for
PrevalenceStudies.ArchOrofSci.2006;1:9-14.
[18] Avwioro OG. (2015). Histochemistry and Tissue Pathology in; Principle and
Technique.Thirdedition,ClaverianunPress,Ibadan,Nigeria.133-168.
[19] Khan S, Dowst H, Huang Q, Noor AB, Godoy G, Zarrin-Khameh N, Castro P,
Scheurer ME, Hilsenbeck SG, Mims MP, Mitsiades N. Role of adenomatous
polyposis coli (APC) gene in SPOP-mutant prostate cancer and clinical
outcomes. JClinOncol.2023;41:doi/pdf/10.1200/JCO.2023.41.6_suppl.
[20] Morais CL, Herawi M, Toubaji A, Albadine R, Hicks J, Netto GJ, De Marzo AM,
Epstein JI, Lotan TL. PTEN loss and ERG protein expression are infrequent in
prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
Prostate.2015;75:1610–1619.
[21] Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G,
Mazzucchelli R, Bainconi M., Stack E.C., et al. A co-clinical approach
identifies mechansims and potential therapies for androgen deprivation
resistanceinprostatecancer.NatureGenet.2013;45:747–755
[22] Lehrer S, McCurdy LD, Stock RG, Kornreich R, Stone NN, C Eng C (2000).
Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate
cancerpatients.CancerGenetCytogenet.122(2):131-133.
[23] Castro-Mujica M. (2022). Clinical implications of the molecular biology of
prostatecancer:Reviewarticle.RevFacMedHum.22(3):597-613.
[24] Breyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR. Confirmation
of the HOXB13 G84E germline mutation in familial prostate cancer.
CancerEpidemiolBiomarkers Prev.2012;21:1348–1353.
Copyright 2023 BioMedSciDirect Publications IJBMR -
All rights reserved.
ISSN: 0976:6685.
c
Olubunmi Ebenezer Esan et al. Int J Biol Med Res. 2024; 15(1): 7712-7717